In vivo, ex vivo, and in vitro studies on apelin's effect on myocardial glucose uptake

Shiming Xu, Pei Han, Mei Huang, Joseph C. Wu, Ching-Pin Chang, Philip S. Tsao, Patrick Yue

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Apelin is an endogenous peptide hormone recently implicated in glucose homeostasis. However, whether apelin affects glucose uptake in myocardial tissue remains undetermined. In this study, we utilized in vivo, ex vivo and in vitro methods to study apelin's effect on myocardial glucose uptake. Pyroglutamated apelin-13 (2 mg/kg/day) was administered to C57BL6/J mice for 7 days. In vivo myocardial glucose uptake was measured by FDG-PET scanning, and GLUT4 translocation was assessed by immunofluorescence imaging. For in vitro studies, differentiated H9C2 cardiomyoblasts were exposed to pyroglutamated apelin-13 (100 nM) for 2 h. To test their involvement in apelin-stimulated myocardial glucose uptake, the energy sensing protein kinase AMPK were inhibited by pharmacologic inhibition (compound C) and RNA interference. IRS-1 phosphorylation was assessed by western blotting using an antibody directed against IRS-1 Ser-789-phosphorylated form. We found that apelin increased myocardial glucose uptake and GLUT4 membrane translocation in C57BL6/J mice. Apelin was also sufficient to increase glucose uptake in H9C2 cells. Apelin-mediated glucose uptake was significantly decreased by AMPK inhibition. Finally, apelin increased IRS-1 Ser-789 phosphorylation in an AMPK-dependent manner. The results of our study demonstrated that apelin increases myocardial glucose uptake through a pathway involving AMPK. Apelin also facilitates IRS-1 Ser-789 phosphorylation, suggesting a novel mechanism for its effects on glucose uptake.

Original languageEnglish (US)
Pages (from-to)320-326
Number of pages7
JournalPeptides
Volume37
Issue number2
DOIs
StatePublished - Oct 2012
Externally publishedYes

Fingerprint

Glucose
AMP-Activated Protein Kinases
Phosphorylation
In Vitro Techniques
Positron emission tomography
Peptide Hormones
RNA Interference
Protein Kinases
Fluorescent Antibody Technique
Homeostasis
Western Blotting
RNA
Tissue
Membranes
Imaging techniques
Antibodies

Keywords

  • AMPK
  • Apelin
  • Glucose uptake
  • Heart
  • IRS-1

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology
  • Physiology
  • Cellular and Molecular Neuroscience

Cite this

Xu, S., Han, P., Huang, M., Wu, J. C., Chang, C-P., Tsao, P. S., & Yue, P. (2012). In vivo, ex vivo, and in vitro studies on apelin's effect on myocardial glucose uptake. Peptides, 37(2), 320-326. https://doi.org/10.1016/j.peptides.2012.08.004

In vivo, ex vivo, and in vitro studies on apelin's effect on myocardial glucose uptake. / Xu, Shiming; Han, Pei; Huang, Mei; Wu, Joseph C.; Chang, Ching-Pin; Tsao, Philip S.; Yue, Patrick.

In: Peptides, Vol. 37, No. 2, 10.2012, p. 320-326.

Research output: Contribution to journalArticle

Xu, S, Han, P, Huang, M, Wu, JC, Chang, C-P, Tsao, PS & Yue, P 2012, 'In vivo, ex vivo, and in vitro studies on apelin's effect on myocardial glucose uptake', Peptides, vol. 37, no. 2, pp. 320-326. https://doi.org/10.1016/j.peptides.2012.08.004
Xu, Shiming ; Han, Pei ; Huang, Mei ; Wu, Joseph C. ; Chang, Ching-Pin ; Tsao, Philip S. ; Yue, Patrick. / In vivo, ex vivo, and in vitro studies on apelin's effect on myocardial glucose uptake. In: Peptides. 2012 ; Vol. 37, No. 2. pp. 320-326.
@article{a2c07c5c410c4f8fbce6b11ce90208ef,
title = "In vivo, ex vivo, and in vitro studies on apelin's effect on myocardial glucose uptake",
abstract = "Apelin is an endogenous peptide hormone recently implicated in glucose homeostasis. However, whether apelin affects glucose uptake in myocardial tissue remains undetermined. In this study, we utilized in vivo, ex vivo and in vitro methods to study apelin's effect on myocardial glucose uptake. Pyroglutamated apelin-13 (2 mg/kg/day) was administered to C57BL6/J mice for 7 days. In vivo myocardial glucose uptake was measured by FDG-PET scanning, and GLUT4 translocation was assessed by immunofluorescence imaging. For in vitro studies, differentiated H9C2 cardiomyoblasts were exposed to pyroglutamated apelin-13 (100 nM) for 2 h. To test their involvement in apelin-stimulated myocardial glucose uptake, the energy sensing protein kinase AMPK were inhibited by pharmacologic inhibition (compound C) and RNA interference. IRS-1 phosphorylation was assessed by western blotting using an antibody directed against IRS-1 Ser-789-phosphorylated form. We found that apelin increased myocardial glucose uptake and GLUT4 membrane translocation in C57BL6/J mice. Apelin was also sufficient to increase glucose uptake in H9C2 cells. Apelin-mediated glucose uptake was significantly decreased by AMPK inhibition. Finally, apelin increased IRS-1 Ser-789 phosphorylation in an AMPK-dependent manner. The results of our study demonstrated that apelin increases myocardial glucose uptake through a pathway involving AMPK. Apelin also facilitates IRS-1 Ser-789 phosphorylation, suggesting a novel mechanism for its effects on glucose uptake.",
keywords = "AMPK, Apelin, Glucose uptake, Heart, IRS-1",
author = "Shiming Xu and Pei Han and Mei Huang and Wu, {Joseph C.} and Ching-Pin Chang and Tsao, {Philip S.} and Patrick Yue",
year = "2012",
month = "10",
doi = "10.1016/j.peptides.2012.08.004",
language = "English (US)",
volume = "37",
pages = "320--326",
journal = "Peptides",
issn = "0196-9781",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - In vivo, ex vivo, and in vitro studies on apelin's effect on myocardial glucose uptake

AU - Xu, Shiming

AU - Han, Pei

AU - Huang, Mei

AU - Wu, Joseph C.

AU - Chang, Ching-Pin

AU - Tsao, Philip S.

AU - Yue, Patrick

PY - 2012/10

Y1 - 2012/10

N2 - Apelin is an endogenous peptide hormone recently implicated in glucose homeostasis. However, whether apelin affects glucose uptake in myocardial tissue remains undetermined. In this study, we utilized in vivo, ex vivo and in vitro methods to study apelin's effect on myocardial glucose uptake. Pyroglutamated apelin-13 (2 mg/kg/day) was administered to C57BL6/J mice for 7 days. In vivo myocardial glucose uptake was measured by FDG-PET scanning, and GLUT4 translocation was assessed by immunofluorescence imaging. For in vitro studies, differentiated H9C2 cardiomyoblasts were exposed to pyroglutamated apelin-13 (100 nM) for 2 h. To test their involvement in apelin-stimulated myocardial glucose uptake, the energy sensing protein kinase AMPK were inhibited by pharmacologic inhibition (compound C) and RNA interference. IRS-1 phosphorylation was assessed by western blotting using an antibody directed against IRS-1 Ser-789-phosphorylated form. We found that apelin increased myocardial glucose uptake and GLUT4 membrane translocation in C57BL6/J mice. Apelin was also sufficient to increase glucose uptake in H9C2 cells. Apelin-mediated glucose uptake was significantly decreased by AMPK inhibition. Finally, apelin increased IRS-1 Ser-789 phosphorylation in an AMPK-dependent manner. The results of our study demonstrated that apelin increases myocardial glucose uptake through a pathway involving AMPK. Apelin also facilitates IRS-1 Ser-789 phosphorylation, suggesting a novel mechanism for its effects on glucose uptake.

AB - Apelin is an endogenous peptide hormone recently implicated in glucose homeostasis. However, whether apelin affects glucose uptake in myocardial tissue remains undetermined. In this study, we utilized in vivo, ex vivo and in vitro methods to study apelin's effect on myocardial glucose uptake. Pyroglutamated apelin-13 (2 mg/kg/day) was administered to C57BL6/J mice for 7 days. In vivo myocardial glucose uptake was measured by FDG-PET scanning, and GLUT4 translocation was assessed by immunofluorescence imaging. For in vitro studies, differentiated H9C2 cardiomyoblasts were exposed to pyroglutamated apelin-13 (100 nM) for 2 h. To test their involvement in apelin-stimulated myocardial glucose uptake, the energy sensing protein kinase AMPK were inhibited by pharmacologic inhibition (compound C) and RNA interference. IRS-1 phosphorylation was assessed by western blotting using an antibody directed against IRS-1 Ser-789-phosphorylated form. We found that apelin increased myocardial glucose uptake and GLUT4 membrane translocation in C57BL6/J mice. Apelin was also sufficient to increase glucose uptake in H9C2 cells. Apelin-mediated glucose uptake was significantly decreased by AMPK inhibition. Finally, apelin increased IRS-1 Ser-789 phosphorylation in an AMPK-dependent manner. The results of our study demonstrated that apelin increases myocardial glucose uptake through a pathway involving AMPK. Apelin also facilitates IRS-1 Ser-789 phosphorylation, suggesting a novel mechanism for its effects on glucose uptake.

KW - AMPK

KW - Apelin

KW - Glucose uptake

KW - Heart

KW - IRS-1

UR - http://www.scopus.com/inward/record.url?scp=84865472301&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865472301&partnerID=8YFLogxK

U2 - 10.1016/j.peptides.2012.08.004

DO - 10.1016/j.peptides.2012.08.004

M3 - Article

C2 - 22906703

AN - SCOPUS:84865472301

VL - 37

SP - 320

EP - 326

JO - Peptides

JF - Peptides

SN - 0196-9781

IS - 2

ER -